Literature DB >> 2143102

Phenotypic analyses of lymphokine-activated killer cells that release interferon gamma and tumor necrosis factor alpha.

A S Chong1, B Ybarrondo, W J Grimes, E M Hersh, P Scuderi.   

Abstract

We recently reported that interleukin-2(IL-2)-activated peripheral blood lymphocytes and CD3+, lymphokine-activated killer (LAK) cell clones release tumor necrosis factor alpha(TNF alpha) and interferon gamma (IFN gamma) when stimulated with K562 erythroleukemia cells. We examined the phenotype of IL-2-activated peripheral blood leukocytes that secrete TNF alpha and IFN gamma when stimulated with K562 cells and demonstrated that TNF alpha secretion is not due to the presence of contaminating mononuclear phagocytes. Further, we demonstrate that IL-2-activated natural killer (NK) cells release only IFN gamma when stimulated with K562 cells while T lymphocytes exposed to monoclonal anti-CD3 and K562 cells secrete both TNF alpha and IFN gamma. However, T cells stimulated only with K562 cells did not release IFN gamma or TNF alpha while the admixture of these T cells with NK cells, when stimulated with K562 cells, released levels of TNF alpha comparable to those produced by the unseparated cells. At present it is unclear whether only one or both effector cell types respond to K562 by releasing TNF alpha or why the presence both cell types is needed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2143102     DOI: 10.1007/bf01789178

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  17 in total

1.  Cytolytic and biochemical properties of cytoplasmic granules of murine lymphokine-activated killer cells.

Authors:  P A Henkart; C C Yue; J Yang; S A Rosenberg
Journal:  J Immunol       Date:  1986-10-15       Impact factor: 5.422

2.  Tumor necrosis factor induction by Candida albicans from human natural killer cells and monocytes.

Authors:  J Y Djeu; D K Blanchard; A L Richards; H Friedman
Journal:  J Immunol       Date:  1988-12-01       Impact factor: 5.422

3.  Natural killer-sensitive targets stimulate production of TNF-alpha but not TNF-beta (lymphotoxin) by highly purified human peripheral blood large granular lymphocytes.

Authors:  P M Peters; J R Ortaldo; M R Shalaby; L P Svedersky; G E Nedwin; T S Bringman; P E Hass; B B Aggarwal; R B Herberman; D V Goeddel
Journal:  J Immunol       Date:  1986-10-15       Impact factor: 5.422

4.  Tumor necrosis factor (TNF).

Authors:  L J Old
Journal:  Science       Date:  1985-11-08       Impact factor: 47.728

5.  Tumor targets stimulate IL-2 activated killer cells to produce interferon-gamma and tumor necrosis factor.

Authors:  A S Chong; P Scuderi; W J Grimes; E M Hersh
Journal:  J Immunol       Date:  1989-03-15       Impact factor: 5.422

6.  Immune interferon: a pleiotropic lymphokine with multiple effects.

Authors:  G Trinchieri; B Perussia
Journal:  Immunol Today       Date:  1985-04

7.  Raised serum levels of tumour necrosis factor in parasitic infections.

Authors:  P Scuderi; K E Sterling; K S Lam; P R Finley; K J Ryan; C G Ray; E Petersen; D J Slymen; S E Salmon
Journal:  Lancet       Date:  1986-12-13       Impact factor: 79.321

8.  Human T cells from autoimmune and normal individuals can produce tumor necrosis factor.

Authors:  M Turner; M Londei; M Feldmann
Journal:  Eur J Immunol       Date:  1987-12       Impact factor: 5.532

9.  Production of tumor necrosis factor/cachectin by human T cell lines and peripheral blood T lymphocytes stimulated by phorbol myristate acetate and anti-CD3 antibody.

Authors:  S S Sung; J M Bjorndahl; C Y Wang; H T Kao; S M Fu
Journal:  J Exp Med       Date:  1988-03-01       Impact factor: 14.307

10.  Lymphokine-activated killer cell phenomenon. II. Precursor phenotype is serologically distinct from peripheral T lymphocytes, memory cytotoxic thymus-derived lymphocytes, and natural killer cells.

Authors:  E A Grimm; K M Ramsey; A Mazumder; D J Wilson; J Y Djeu; S A Rosenberg
Journal:  J Exp Med       Date:  1983-03-01       Impact factor: 14.307

View more
  4 in total

1.  Differential secretion of TNF-alpha and IFN-gamma by human peripheral blood-derived NK subsets and association with functional maturation.

Authors:  A Jewett; X H Gan; L T Lebow; B Bonavida
Journal:  J Clin Immunol       Date:  1996-01       Impact factor: 8.317

2.  Monoclonal antibodies anti-CD3, anti-TCR alpha beta and anti-CD2 act synergistically with tumor cells to stimulate lymphokine-activated killer cells and tumor-infiltrating lymphocytes to secrete interferon gamma.

Authors:  A S Chong; E D Staren; P Scuderi
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

3.  ICAM-1 and LFA-3 enhance the ability of anti-CD3 mAb to stimulate interferon gamma production in interleukin-2-activated T cells.

Authors:  A S Chong; X L Jiang; P Scuderi; M Lamas; L H Graf
Journal:  Cancer Immunol Immunother       Date:  1994-08       Impact factor: 6.968

4.  Lymphokine-activated killer cell function of peripheral blood mononuclear cells, spleen cells and regional lymph node cells in gastric cancer patients.

Authors:  N Karimine; S Arinaga; H Inoue; S Nanbara; H Ueo; T Akiyoshi
Journal:  Clin Exp Immunol       Date:  1994-06       Impact factor: 4.330

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.